References
- Kalediene R, Nadisauskiene R. Women's health, changes and challenges in health policy development in Lithuania. Reprod Health Matters 2002; 10: 117–126
- Westoff C F. Recent trends in abortion and contraception in 12 countries. ORC Macro, Calverton, MD 2005, (DHS Analytical Studies No. 8)
- Jakubc✓ionytė R Determinants for induced abortion. Kaunas Medical University, Kaunas, 2000, [doctoral dissertation]
- Berer M. Why medical abortion is important for women [editorial]. Reprod Health Matters 2005; 13: 6–10
- Stankuniene V, Mitrikas A A. Seima ir gimstamumas Lietuvoje [Family and fertility in Lithuania]. Lietuvos filosofijos ir sociologijos institutes, Vilnius 1997
- Klijzing E. Are there unmet family planning needs in Europe?. Fam Plann Perspect 2000; 32: 74–81; 88
- Safe abortion: technical and policy guidance for health systems. World Health Organization (WHO), Geneva 2003, (http://www.who.int/reproductive-health/publications/safe_abortion, accessed 28 April 2006)
- Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. Br Med J 2000; 320: 79–82
- Jones R, Henshaw S K. Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden. Perspect Sex Reprod Health 2002; 34: 154–161
- , et al. Sharing responsibility: women, society and abortion worldwide. Alan Guttmacher Institute, New York 1999
- Knudsen L B, Gissler M, Bender S B, et al. Induced abortion in the Nordic countries: special emphasis on young women. Acta Obstet Gynecol Scand 2003; 82: 257–268